Company at a Glance
Price
Infographic
Overview
Merck is a global pharmaceutical and chemical company founded in 1668 in Darmstadt, Germany. It was originally a supplier of traditional chemicals, but later expanded into pharmaceuticals, life sciences, and performance materials. Merck is also known as Merck KGaA, as it is a family-owned company with around 50% of its shares controlled by the descendants of its founder, Friedrich Jacob Merck.
The company has a strong presence in Europe and the United States, as well as in emerging markets such as China, India, and Latin America. It employs over 57,000 people and generates annual revenues of around 14 billion euros.
Merck's pharmaceutical division focuses on developing and commercializing innovative medicines in various therapeutic areas, including oncology, neurology, immunology, and cardiovascular diseases. Its life sciences division provides products and services for research, development, and production in the biopharmaceutical and biotechnological industries. The performance materials division provides materials and technologies for various industries, including healthcare, electronics, coatings, and cosmetics.
The company's mission is to "empower scientists and engineers to create and make life-changing innovations that improve people's lives." It is committed to sustainability and has set ambitious targets to reduce its environmental impact, promote diversity and inclusion, and improve access to healthcare for underserved populations.
Merck is also actively involved in corporate social responsibility initiatives, including providing disaster relief and supporting education and community development programs around the world.
How to explain to a 10 year old kid about the company?
π Want to read more about Merck?
Sign up for free
or
log in
π Your free copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks" is waiting
TWVyY2sgaX MgYSBiaWcg Y29tcGFueS B0aGF0IGhl bHBzIHBlb3 BsZSBzdGF5 IGhlYWx0aH kuIEltYWdp bmUgaXQgbG lrZSBhIHN1 cGVyaGVyby Bmb3IgaGVh bHRoISBUaG V5IGNyZWF0 ZSBtZWRpY2 luZXMgYW5k IHZhY2Npbm VzIHRoYXQg aGVscCBmaW dodCBvZmYg ZGlzZWFzZX MsIHdoaWNo IGlzIHZlcn kgaW1wb3J0 YW50IGZvci BrZWVwaW5n IHBlb3BsZS BzYWZlIGFu ZCB3ZWxsLi A8YnI+U28s IGhvdyBkb2 VzIE1lcmNr IG1ha2UgbW 9uZXk/IFdo ZW4gZG9jdG 9ycyBhbmQg aG9zcGl0YW xzIHVzZSB0 aGVpciBtZW RpY2luZXMg YW5kIHZhY2 NpbmVzIHRv IGhlbHAgcG F0aWVudHMs IHRoZXkgcG F5IE1lcmNr IGZvciB0aG VtLiBJdOKA mXMga2luZC BvZiBsaWtl IGhvdyB5b3 UgYnV5IGEg dG95IGZyb2 0gYSBzdG9y ZS4gVGhlIG 1vcmUgcGVv cGxlIHRoYX QgbmVlZCB0 aGVpciBtZW RpY2luZXMs IHRoZSBtb3 JlIG1vbmV5 IHRoZSBjb2 1wYW55IG1h a2VzLjxicj 5Ob3csIHdo eSBpcyBNZX JjayBzdWNj ZXNzZnVsPy BXZWxsLCB0 aGV5IGRvIG EgbG90IG9m IHJlc2Vhcm NoIHRvIGRp c2NvdmVyIG 5ldyBtZWRp Y2luZXMgdG hhdCBjYW4g aGVscCB3aX RoIGRpZmZl cmVudCBoZW FsdGggcHJv YmxlbXMuIF RoZXkgYWxz byB0cnkgdG 8gbWFrZSBz dXJlIHRoZW lyIHByb2R1 Y3RzIGFyZS BzYWZlIGFu ZCBlZmZlY3 RpdmUgZm9y IGV2ZXJ5b2 5lLiBQbHVz LCBhcyBtb3 JlIHBlb3Bs ZSBpbiB0aG Ugd29ybGQg bmVlZCBoZW FsdGhjYXJl LCBNZXJja+ KAmXMgd29y ayBiZWNvbW VzIG1vcmUg aW1wb3J0YW 50Ljxicj5B cyBmb3IgdG hlIGZ1dHVy ZSwgTWVyY2 sgaXMgbGlr ZWx5IHRvIH N0YXkgc3Vj Y2Vzc2Z1bC BiZWNhdXNl IHRoZXkgYX JlIGFsd2F5 cyB3b3JraW 5nIG9uIG5l dyBpZGVhcy BhbmQgdHJl YXRtZW50cy 4gVGhleSBp bnZlc3QgYS Bsb3QgaW4g c2NpZW5jZS BhbmQgaW5u b3ZhdGlvbi wgd2hpY2gg bWVhbnMgdG hleSBhcmUg YWx3YXlzIG xvb2tpbmcg Zm9yIGJldH RlciB3YXlz IHRvIGhlbH AgcGVvcGxl LiBBbmQgd2 l0aCBuZXcg Y2hhbGxlbm dlcywgbGlr ZSBuZXcgZG lzZWFzZXMs IHRoZXJlIH dpbGwgYWx3 YXlzIGJlIG EgbmVlZCBm b3IgZ29vZC BtZWRpY2lu ZXMsIHNvIE 1lcmNrIHdp bGwga2VlcC BwbGF5aW5n IGEga2V5IH JvbGUgaW4g aGVhbHRoIG NhcmUuPGJy Pg==
What is special about the company?
π Want to read more about Merck?
Sign up for free
or
log in
π Get insights from "The Checklist Value Investor β A Smarter Way to Pick Stocks" now!
TWVyY2sgaX MgYSBnbG9i YWwgcGhhcm 1hY2V1dGlj YWwgYW5kIG hlYWx0aGNh cmUgY29tcG FueSB0aGF0 IGhhcyBiZW VuIGluIG9w ZXJhdGlvbi Bmb3Igb3Zl ciAzNTAgeW VhcnMsIG1h a2luZyBpdC BvbmUgb2Yg dGhlIG9sZG VzdCBhbmQg bGFyZ2VzdC BwaGFybWFj ZXV0aWNhbC Bjb21wYW5p ZXMgaW4gdG hlIHdvcmxk LiBJdCBoYX MgYSBsb25n IGhpc3Rvcn kgb2YgaW5u b3ZhdGlvbi BhbmQgcmVz ZWFyY2gsIG xlYWRpbmcg dG8gdGhlIG RldmVsb3Bt ZW50IG9mIG 51bWVyb3Vz IG1lZGljYX Rpb25zIGFu ZCB2YWNjaW 5lcyB0aGF0 IGhhdmUgc2 lnbmlmaWNh bnRseSBpbX Byb3ZlZCBn bG9iYWwgaG VhbHRoLiBU aGUgY29tcG FueSBhbHNv IGhhcyBhIH N0cm9uZyBj b21taXRtZW 50IHRvIHN1 c3RhaW5hYm lsaXR5IGFu ZCBjb3Jwb3 JhdGUgcmVz cG9uc2liaW xpdHksIGVt cGhhc2l6aW 5nIGV0aGlj YWwgYnVzaW 5lc3MgcHJh Y3RpY2VzIG FuZCBnaXZp bmcgYmFjay B0byB0aGUg Y29tbXVuaX RpZXMgaW4g d2hpY2ggaX Qgb3BlcmF0 ZXMuIE1lcm NrIGlzIGFs c28ga25vd2 4gZm9yIGl0 cyBkaXZlcn NlIHdvcmtm b3JjZSBhbm QgaW5jbHVz aXZlIGN1bH R1cmUsIHdp dGggYSBmb2 N1cyBvbiBw cm9tb3Rpbm cgZGl2ZXJz aXR5IGFuZC BpbmNsdXNp b24gaW4gYW xsIGFzcGVj dHMgb2YgaX RzIG9wZXJh dGlvbnMuIE FkZGl0aW9u YWxseSwgTW VyY2sgaGFz IGEgc3Ryb2 5nIGZvY3Vz IG9uIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCBh bmQgaW52ZX N0cyBoZWF2 aWx5IGluIG 5ldyB0ZWNo bm9sb2dpZX MgYW5kIGlu bm92YXRpb2 5zIHRvIGNv bnRpbnVlIG RyaXZpbmcg c2NpZW50aW ZpYyBhZHZh bmNlbWVudH MgaW4gdGhl IGhlYWx0aG NhcmUgaW5k dXN0cnkuIE 92ZXJhbGws IE1lcmNrJ3 MgZGVkaWNh dGlvbiB0by BpbXByb3Zp bmcgZ2xvYm FsIGhlYWx0 aCwgY29tbW l0bWVudCB0 byBldGhpY2 FsIGFuZCBy ZXNwb25zaW JsZSBidXNp bmVzcyBwcm FjdGljZXMs IGFuZCBlbX BoYXNpcyBv biBkaXZlcn NpdHkgYW5k IHJlc2Vhcm NoIG1ha2Ug aXQgYSB1bm lxdWUgYW5k IHJlc3BlY3 RlZCBjb21w YW55IGluIH RoZSBwaGFy bWFjZXV0aW NhbCBpbmR1 c3RyeS4=
What the company's business model?
π Want to read more about Merck?
Sign up for free
or
log in
π Free download! "The Checklist Value Investor β A Smarter Way to Pick Stocks"
VGhlIE1lcm NrIGNvbXBh bnkgaXMgYS BnbG9iYWwg cGhhcm1hY2 V1dGljYWwg Y29tcGFueS B0aGF0IG9w ZXJhdGVzIH VuZGVyIGEg dHJhZGl0aW 9uYWwgYnVz aW5lc3MgbW 9kZWwuIFRo aXMgbWVhbn MgdGhhdCBp dCBjcmVhdG VzLCBtYW51 ZmFjdHVyZX MsIGFuZCBt YXJrZXRzIH ByZXNjcmlw dGlvbiBkcn VncywgdmFj Y2luZXMsIG Jpb2xvZ2lj IHRoZXJhcG llcywgYW5p bWFsIGhlYW x0aCBwcm9k dWN0cywgYW 5kIG92ZXIt dGhlLWNvdW 50ZXIgbWVk aWNhdGlvbn MuIFRoZSBj b21wYW55J3 MgbWFpbiBy ZXZlbnVlIH NvdXJjZSBp cyB0aHJvdW doIHRoZSBz YWxlIG9mIH RoZXNlIHBy b2R1Y3RzIH RvIGhlYWx0 aCBjYXJlIH Byb2Zlc3Np b25hbHMgYW 5kIGRpcmVj dGx5IHRvIG NvbnN1bWVy cy4gTWVyY2 sgYWxzbyBl bmdhZ2VzIG luIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCBvZi BuZXcgbWVk aWNpbmVzLC BhbmQgaGFz IGEgbGFyZ2 UgcG9ydGZv bGlvIG9mIH Byb2R1Y3Rz IGZvY3VzZW Qgb24gdGhl cmFwZXV0aW MgYXJlYXMg c3VjaCBhcy BvbmNvbG9n eSwgY2FyZG lvdmFzY3Vs YXIgZGlzZW FzZXMsIHZh Y2NpbmVzLC BpbmZlY3Rp b3VzIGRpc2 Vhc2VzLCBh bmQgYW5pbW FsIGhlYWx0 aC4gSW4gYW RkaXRpb24g dG8gZGV2ZW xvcGluZyBh bmQgc2VsbG luZyBpdHMg b3duIHByb2 R1Y3RzLCBN ZXJjayBhbH NvIGVuZ2Fn ZXMgaW4gcG FydG5lcnNo aXBzIGFuZC Bjb2xsYWJv cmF0aW9ucy B3aXRoIG90 aGVyIGNvbX BhbmllcyBp biB0aGUgaG VhbHRoY2Fy ZSBpbmR1c3 RyeS4=
Is AI a threat?
AI can impact Merck and its competitive positioning across various dimensions, though the extent of the threat can vary based on specific circumstances.
1. Substitution: AI technologies can potentially lead to the development of new products or therapies that offer alternative solutions to traditional pharmaceuticals. For example, AI-driven drug discovery platforms can identify novel compounds faster and more efficiently than traditional methods. If competitors successfully leverage AI to develop more effective treatments, Merck could face pressure on its product offerings.
2. Disintermediation: AI can streamline processes and reduce the need for certain intermediaries in the healthcare supply chain. For instance, telemedicine and digital health platforms can create direct interactions between patients and healthcare providers, bypassing traditional routes. If patients increasingly rely on AI-driven solutions for diagnosis and treatment recommendations, Merck might see shifts in how its products are marketed and accessed.
3. Margin Pressure: The use of AI in drug development and manufacturing can lead to cost reductions, which may create margin pressure for established pharmaceutical companies like Merck. If competitors utilize AI to produce similar products at a lower cost or bring drugs to market more quickly, Merck may need to adjust its pricing strategy or invest in technology to maintain its margins.
Overall, while AI does pose potential threats to Merck regarding substitution, disintermediation, and margin pressure, it can also represent an opportunity for the company to enhance its own capabilities, drive innovation, and improve efficiencies across its operations. The net effect will depend on how well Merck adapts and integrates AI into its strategies.
Sensitivity to interest rates
The sensitivity of Merck & Co.βs earnings, cash flow, and valuation to changes in interest rates can be analyzed through several factors:
1. Earnings Sensitivity: Merckβs earnings are indirectly sensitive to interest rates. Higher interest rates can lead to increased borrowing costs if the company needs to finance operations, research and development, or acquisitions. Additionally, higher rates may constrain consumer spending, potentially impacting sales of pharmaceuticals. Conversely, lower interest rates may facilitate capital investment and expansion.
2. Cash Flow Sensitivity: Merckβs cash flow can be affected by interest rates primarily through its debt obligations. If interest rates rise, the cost of servicing any variable-rate debt will increase, potentially reducing free cash flow. Lower rates can positively impact cash flow by lowering interest expenses. Moreover, changes in interest rates can influence the timing and amount of cash flows received from customers, especially in a tight economic environment.
3. Valuation Sensitivity: The valuation of Merck, like other companies, is sensitive to changes in interest rates due to the discounted cash flow (DCF) methodology generally used to estimate a companyβs value. When interest rates rise, the discount rate used in DCF calculations increases, which can lead to a lower present value of future cash flows, thus reducing the companyβs valuation. Conversely, lower interest rates can enhance valuation by lowering the discount rate and increasing the present value of future cash flows.
In summary, while Merckβs operations can be influenced by changes in interest rates, the sensitivity may not be as pronounced as in highly leveraged companies. The impact on earnings, cash flow, and valuation will depend on the companyβs debt levels, capital structure, and market dynamics.
Resilience to the future changes
π Want to read more about Merck?
Sign up for free
or
log in
π Donβt miss "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!
QSByZWFsaX N0aWMgc2Nl bmFyaW8gdG hhdCBjb3Vs ZCBwZXJtYW 5lbnRseSBp bXBhaXIgTW VyY2vigJlz IGVjb25vbW ljcyBvdmVy IHRoZSBuZX h0IDMtNSB5 ZWFycyBpcy B0aGUgbG9z cyBvZiBwYX RlbnQgcHJv dGVjdGlvbi Bmb3IgaXRz IGtleSBkcn VncywgcGFy dGljdWxhcm x5IEtleXRy dWRhLCBpdH MgbGVhZGlu ZyBpbW11bm 8tb25jb2xv Z3kgdHJlYX RtZW50LiBJ ZiBLZXl0cn VkYSBsb3Nl cyBwYXRlbn QgcHJvdGVj dGlvbiBhbm QgZmFjZXMg cm9idXN0IG dlbmVyaWMg Y29tcGV0aX Rpb24gc29v bmVyIHRoYW 4gYW50aWNp cGF0ZWQsIE 1lcmNrIG1h eSBleHBlcm llbmNlIGEg c2lnbmlmaW NhbnQgZHJv cCBpbiByZX ZlbnVlLiBB ZGRpdGlvbm FsbHksIGlm IG5ldyBlbn RyYW50cyBp biB0aGUgb2 5jb2xvZ3kg bWFya2V0IG FyZSBhYmxl IHRvIG9mZm VyIGVxdWl2 YWxlbnQgb3 Igc3VwZXJp b3IgdGhlcm FwaWVzIGF0 IGEgbG93ZX IgY29zdCwg dGhpcyBjb3 VsZCBmdXJ0 aGVyIGVyb2 RlIE1lcmNr 4oCZcyBtYX JrZXQgc2hh cmUuPGJyPk luIHRoaXMg c2NlbmFyaW 8sIE1lcmNr 4oCZcyBtYX JnaW5zIHdv dWxkIGJlIG FkdmVyc2Vs eSBhZmZlY3 RlZC4gVGhl IGNvbXBhbn kgbWlnaHQg c2VlIGl0cy Bncm9zcyBt YXJnaW4gZG VjbGluZSBh cyBpdCBhZG p1c3RzIHBy aWNpbmcgc3 RyYXRlZ2ll cyB0byBjb2 1wZXRlIHdp dGggZ2VuZX JpY3MsIHdo aWxlIGFsc2 8gaW5jdXJy aW5nIGNvc3 RzIGFzc29j aWF0ZWQgd2 l0aCBtYWlu dGFpbmluZy BtYXJrZXQg cHJlc2VuY2 UgdGhyb3Vn aCBkaXNjb3 VudHMgYW5k IHJlYmF0ZX MuIE9wZXJh dGluZyBtYX JnaW5zIHdv dWxkIGJlIH NxdWVlemVk IGFzIHdlbG wsIHJlZmxl Y3RpbmcgYS BuZWVkIHRv IGludmVzdC BoZWF2aWx5 IGluIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCB0 byByZXBsYW NlIGxvc3Qg cmV2ZW51ZS BzdHJlYW1z IGFuZCB0by BlbmhhbmNl IG1hcmtldG luZyBlZmZv cnRzIHRvIH N0aW11bGF0 ZSBleGlzdG luZyBwcm9k dWN0cy48Yn I+Q2FzaCBm bG93IHdvdW xkIGxpa2Vs eSBkZXRlcm lvcmF0ZSBz aWduaWZpY2 FudGx5LiBB IHNoYXJwIG RlY3JlYXNl IGluIHNhbG VzIGZyb20g S2V5dHJ1ZG EgY291bGQg bGVhZCB0by BvcGVyYXRp b25hbCBjYX NoIGZsb3cg ZHJvcHBpbm cgc3Vic3Rh bnRpYWxseS wgbGltaXRp bmcgdGhlIG FiaWxpdHkg dG8gaW52ZX N0IGluIG5l dyBwcm9kdW N0cyBvciBp bml0aWF0aX Zlcy4gSWYg dGhlIGNhc2 ggZmxvdyBp cyBpbnN1Zm ZpY2llbnQg dG8gbWVldC BvYmxpZ2F0 aW9ucywgTW VyY2sgbWln aHQgcmVzb3 J0IHRvIGlu Y3JlYXNlZC Bib3Jyb3dp bmcgb3IgY3 V0dGluZyBk b3duIG9uIG NhcGl0YWwg ZXhwZW5kaX R1cmVzLCBm dXJ0aGVyIH N0cmFpbmlu ZyBpdHMgZm luYW5jaWFs IHBvc2l0aW 9uLjxicj5P biB0aGUgYm FsYW5jZSBz aGVldCwgTW VyY2sgY291 bGQgc2VlIG EgbWFya2Vk IGluY3JlYX NlIGluIGxp YWJpbGl0aW VzIGlmIHRo ZXkgdG9vay BvbiBhZGRp dGlvbmFsIG RlYnQgdG8g bWFuYWdlIG Nhc2ggZmxv dyBpc3N1ZX MuIFRoaXMg d291bGQgcm Fpc2UgdGhl aXIgZGVidC 10by1lcXVp dHkgcmF0aW 8sIGluZGlj YXRpbmcgaW 5jcmVhc2Vk IGZpbmFuY2 lhbCByaXNr LiBNZWFud2 hpbGUsIHJl dGFpbmVkIG Vhcm5pbmdz IG1pZ2h0IG RlY3JlYXNl IGFzIHRoZS Bjb21wYW55 IHN0cnVnZ2 xlcyB0byBt YWludGFpbi Bwcm9maXRh YmlsaXR5LC B3aGljaCBj b3VsZCBhZm ZlY3Qgc2hh cmVob2xkZX IgZXF1aXR5 IGFuZCBvdm VyYWxsIGZp bmFuY2lhbC BzdGFiaWxp dHkuPGJyPk 92ZXJhbGws IHN1Y2ggYS BzY2VuYXJp byBjb3VsZC BsZWFkIHRv IGEgZGltaW 5pc2hlZCBj b21wZXRpdG l2ZSBwb3Np dGlvbiBmb3 IgTWVyY2ss IGEgbW9yZS B2b2xhdGls ZSBlYXJuaW 5ncyBwcm9m aWxlLCBhbm QgYSBwb3Rl bnRpYWxseS BuZWdhdGl2 ZSBwZXJjZX B0aW9uIGlu IHRoZSBtYX JrZXQsIGlt cGFjdGluZy BzdG9jayBw ZXJmb3JtYW 5jZSBhbmQg aW52ZXN0b3 IgY29uZmlk ZW5jZS48Yn I+
Interesting facts about the company
π Want to read more about Merck?
Sign up for free
or
log in
π Your free copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks" is waiting
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvNX owZmx5ZTJB cEZ0SVRRMD FCZFkud2Vi cCIgYWx0PS JNZXJjayIg dGl0bGU9Ik 1lcmNrIiAg Y2xhc3M9Im ltZy1mbHVp ZCIgaGVpZ2 h0PTUwIHdp ZHRoPTUwIG xvYWRpbmc9 J2xhenknIH N0eWxlPSdi b3JkZXItcm FkaXVzOiA2 cHg7Jz4KCi AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nZmxleDog MTsgdGV4dC 1hbGlnbjog Y2VudGVyOy BtYXJnaW4t bGVmdDogNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdmb250LX NpemU6IDI2 cHg7IGNvbG 9yOiAjMzMz OyBtYXJnaW 4tYm90dG9t OiAxNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Dwn5OIIFdh bnQgdG8gcm VhZCBtb3Jl IGFib3V0IE 1lcmNrPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TnSBKb2lu IHVzIGFuZC BncmFiIHlv dXIgY29weS BvZiA8aT4i VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr cyI8L2k+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvcD4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwhLS0KIC AgICAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nbWFy Z2luLXRvcD ogMTJweDsg Zm9udC1zaX plOiAxM3B4 OyBjb2xvcj ogIzQ0NDsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bub3cgYW5k IGdldCBvdX IgZnJlZSBl Qm9vayAKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxiPl RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 M8L2I+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx NnB4OyBmb2 50LXNpemU6 IDE0cHg7IG NvbG9yOiAj NDQ0OyBmb2 50LWZhbWls eTogLWFwcG xlLXN5c3Rl bSwgQmxpbm tNYWNTeXN0 ZW1Gb250LC BTZWdvZSBV SSwgUm9ib3 RvLCBIZWx2 ZXRpY2EgTm V1ZSwgc2Fu cy1zZXJpZj sgbGluZS1o ZWlnaHQ6ID EuNjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgSGF2 ZSB5b3UgaG VhcmQgYWJv dXQgb3VyIH Nob3J0IDxz dHJvbmcgc3 R5bGU9J2Zv bnQtd2VpZ2 h0OiA2MDA7 Jz5EYWlseS BWaWRlbyBO ZXdzbGV0dG VyPC9zdHJv bmc+PwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naHR0 cHM6Ly93d3 cuaW5zaWdo dGZ1bHZhbH VlLmNvbS9u ZXdzbGV0dG VyLnBocCcg dGFyZ2V0PS dfYmxhbmsn IHN0eWxlPS djb2xvcjog IzAwN0JGRj sgdGV4dC1k ZWNvcmF0aW 9uOiBub25l OyBmb250LX dlaWdodDog NTAwOyBtYX JnaW4tbGVm dDogNnB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgRmlu ZCBvdXQgbW 9yZQogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIAogIC AgICAgIAog ICAgICAgID xzcGFuIGNs YXNzPSdibH VycmVkLXRl eHQnPgogIC AgICAgICAg ICBUV1Z5WT JzZ0ptIEZ0 Y0RzZ1EyOH UgTENCcmJt OTNiaSBCaG N5Qk5VMFFn IGIzVjBjMm xrWlMgQjBh R1VnVlc1cC BkR1ZrSUZO MFlYIFJsY3 lCaGJtUWcg UTJGdVlXUm hMQyBCcGN5 QnZibVVnIG IyWWdkR2hs SUcgeGhjbW RsYzNRZyBj R2hoY20xaF kyIFYxZEds allXd2cgWT I5dGNHRnVh VyBWeklHbH VJSFJvIFpT QjNiM0pzWk MgNGdTR1Z5 WlNCaCBjbV VnYzI5dFpT IEJwYm5SbG NtVnogZEds dVp5Qm1ZVy BOMGN5QmhZ bTkxIGRDQj BhR1VnWTIg OXRjR0Z1ZV RvOCBZbkkr TVM0Z1NHIG x6ZEc5eWVU b2cgVFdWeV kyc2dkMiBG eklHOXlhV2 RwIGJtRnNi SGtnWm0gOT FibVJsWkNC cCBiaUF4T0 RreElHIEZ6 SUhSb1pTQl YgTGxNdUlI TjFZbiBOcF pHbGhjbmtn IGIyWWdkR2 hsSUUgZGxj bTFoYmlCTi BaWEpqYXlC bVlXIDFwYk hrZ1kyOXQg Y0dGdWVTd2 dkMiBocFky Z2daR0YwIF pYTWdZbUZq YXkgQjBieU F4TmpZNCBM aUJVYUdVZ1 ZTIDVUTGlC aWNtRnUgWT JnZ1ltVmpZ VyAxbElHbH VaR1Z3IFpX NWtaVzUwSU cgUjFjbWx1 WnlCWCBiM0 pzWkNCWFlY IElnU1M0OF luSSsgTWk0 Z1NXNXViMy BaaGRHbHZi am9nIFRXVn lZMnNnYUcg RnpJR0psWl c0ZyBjbVZ6 Y0c5dWMyIG xpYkdVZ1pt OXkgSUhObG RtVnlZVyB3 Z1ozSnZkVz VrIFluSmxZ V3RwYm0gY2 daSEoxWjNN ZyBZVzVrSU haaFkyIE5w Ym1WeklHOT IgWlhJZ2RH aGxJSCBsbF lYSnpMQ0Jw IGJtTnNkV1 JwYm0gY2dk R2hsSUdSbC BkbVZzYjNC dFpXIDUwSU c5bUlIUm8g WlNCbWFYSn pkQyBCdFpX RnpiR1Z6IE lIWmhZMk5w Ym0gVWdhVz RnZEdobCBJ REU1TmpCek xDIEIwYUdV Z1NGQlcgSU haaFkyTnBi bSBVZ1IyRn laR0Z6IGFX d3NJR0Z1Wk MgQjBhR1Vn WTJodiBiR1 Z6ZEdWeWIy IHd0Ykc5M1 pYSnAgYm1j Z1pISjFaeS BCYWIyTnZj aTQ4IFluSS tNeTRnVW0g VnpaV0Z5WT JnZyBSbTlq ZFhNNklFID FsY21OcklH bHUgZG1Wem RITWdhRyBW aGRtbHNlU0 JwIGJpQnla WE5sWVggSm phQ0JoYm1R ZyBaR1YyWl d4dmNHIDFs Ym5RdUlGUm 8gWlNCamIy MXdZVyA1NU lHaGhjeUJo IElHeHZibW N0YzMgUmhi bVJwYm1jZy BZMjl0Ylds MGJXIFZ1ZE NCMGJ5Qmgg WkhaaGJtTn BibSBjZ2FH VmhiSFJvIF kyRnlaU0Iw YUggSnZkV2 RvSUhOaiBh V1Z1WTJVZ1 lXIDVrSUdo aGN5QmggSU dScGRtVnlj MiBVZ2NHbH daV3hwIGJt VWdkR2hoZE MgQnBibU5z ZFdSbCBjeU IwY21WaGRH IDFsYm5Sek lHWnYgY2lC a2FXRmlaWC BSbGN5d2dZ MkZ1IFkyVn lMQ0JoYm0g UWdhVzVtWl dOMCBhVzkx Y3lCa2FYIE 5sWVhObGN5 NDggWW5JK0 5DNGdSMiB4 dlltRnNJRk psIFlXTm9P aUJOWlggSm pheUJ2Y0dW eSBZWFJsY3 lCcGJpIEJ0 YjNKbElIUm 8gWVc0Z01U UXdJRyBOdm RXNTBjbWxs IGN5d2diV0 ZyYVcgNW5J R2wwY3lCdy BjbTlrZFdO MGN5IEJoWT JObGMzTnAg WW14bElIUn ZJRyBFZ2My bG5ibWxtIG FXTmhiblFn Y0cgOXlkR2 x2YmlCdiBa aUIwYUdVZ1 oyIHh2WW1G c0lIQnYgY0 hWc1lYUnBi MiA0dUlFbD BjeUJuIGJH OWlZV3dnY0 ggSmxjMlZ1 WTJVZyBZV3 hzYjNkeklH IFp2Y2lCa2 FYWmwgY25O bElHMWhjbS B0bGRITWdZ VzVrIElIQm hjblJ1Wlgg SnphR2x3Y3 k0OCBZbkkr TlM0Z1EyID l0YldsMGJX VnUgZENCMG J5QlRkWCBO MFlXbHVZV0 pwIGJHbDBl VG9nVFcgVn lZMnNnYUdG eiBJRzFoWk dVZ2MzIFJ5 YVdSbGN5Qn AgYmlCemRY TjBZVyBsdV lXSnNaU0J3 IGNtRmpkR2 xqWlggTXNJ R0ZwYldsdS BaeUIwYnlC eVpXIFIxWT JVZ2FYUnog SUdWdWRtbH liMiA1dFpX NTBZV3dnIF ptOXZkSEJ5 YVcgNTBJR0 Z1WkNCbSBi Mk4xYzJsdV p5IEJ2YmlC eVpYTncgYj I1emFXSnNa UyBCemIzVn lZMmx1IFp5 d2daVzVsY2 0gZDVJR1Zt Wm1saiBhV1 Z1WTNrc0lH IEZ1WkNCM1 lYTjAgWlNC eVpXUjFZMy BScGIyNGdh VzRnIGFYUn pJRzFoYm4g Vm1ZV04wZF hKcCBibWNn Y0hKdlkyIF Z6YzJWekxq eGkgY2o0Mk xpQk5aWCBK amF5Qk5ZVz UxIFlXdzZJ RTFsY20gTn JJSEIxWW14 cCBjMmhsY3 lCMGFHIFVn VFdWeVkyc2 cgVFdGdWRX RnNMQyBCaE lIZHBaR1Zz IGVTQnlaWE 53WlcgTjBa V1FnYldWay BhV05oYkNC eVpXIFpsY2 1WdVkyVWcg WW05dmF5Qj FjMiBWa0lH SjVJR2hsIF lXeDBhR05o Y20gVWdjSE p2Wm1WeiBj Mmx2Ym1Gc2 N5IDRnU1hR Z2FHRnogSU dKbFpXNGdh VyA0Z2NIVm liR2xqIFlY UnBiMjRnYz IgbHVZMlVn TVRnNSBPU0 JoYm1RZ2FY IE1nWVhaaG FXeGggWW14 bElHbHVJRy AxMWJIUnBj R3hsIElHeG hibWQxWVcg ZGxjeTQ4WW 5JKyBOeTRn UTI5eWNHID l5WVhSbElG TnYgWTJsaG JDQlNaWCBO d2IyNXphV0 pwIGJHbDBl VG9nVFcgVn lZMnNnYVhN ZyBhVzUyYj J4MlpXIFFn YVc0Z2RtRn kgYVc5MWN5 QndhRyBsc1 lXNTBhSEp2 IGNHbGpJR2 x1YVggUnBZ WFJwZG1Wei BMQ0JwYm1O c2RXIFJwYm 1jZ1lXTmog WlhOeklIUn ZJRyAxbFpH bGphVzVsIG N5QmhibVFn YUcgVmhiSF JvWTJGeSBa U0J3Y205bm NtIEZ0Y3lC cGJpQjEgYm 1SbGNuTmxj biBabFpDQm piMjF0IGRX NXBkR2xsY3 kgQmhjbTkx Ym1RZyBkR2 hsSUhkdmNt IHhrTGlCVW FHVjUgSUda dlkzVnpJRy A5dUlHMWhh Mmx1IFp5Qm 9aV0ZzZEcg aGpZWEpsSU cxdiBjbVVn WlhGMWFYIF JoWW14bElH RnUgWkNCaF kyTmxjMyBO cFlteGxMan hpIGNqNDRM aUJCYm0gbH RZV3dnU0dW aCBiSFJvT2 lCSmJpIEJo WkdScGRHbH YgYmlCMGJ5 Qm9kVyAxaG JpQndhR0Z5 IGJXRmpaWF YwYVcgTmhi SE1zSUUxbC BjbU5ySUds eklHIEVnYk dWaFpHVnkg SUdsdUlIWm xkRyBWeWFX NWhjbmtnIG JXVmthV05w Ym0gVXVJRT FsY21OciBJ RUZ1YVcxaG JDIEJJWldG c2RHZ2cgYj JabVpYSnpJ SCBaaFkyTn BibVZ6IElH RnVaQ0J3YU cgRnliV0Zq WlhWMCBhV0 5oYkhNZ1pt IDl5SUd4cG RtVnogZEc5 amF5QmhibS BRZ1kyOXRj R0Z1IGFXOX VJR0Z1YVcg MWhiSE1zSU dOdiBiblJ5 YVdKMWRHIG x1WnlCemFX ZHUgYVdacF kyRnVkRyB4 NUlIUnZJSF psIGRHVnlh VzVoY24ga2 dZMkZ5WlM0 OCBZbkkrT1 M0Z1UzIFJ5 YjI1bklGQn AgY0dWc2FX NWxPaSBCVW FHVWdZMjl0 IGNHRnVlU0 JvWVggTWdZ U0J5YjJKMS BjM1FnY0ds d1pXIHhwYm 1VZ2IyWWcg WkhKMVozTW dhVyA0Z2Rt RnlhVzkxIG N5QnpkR0Zu WlggTWdiMl lnWkdWMiBa V3h2Y0cxbG JuIFFzSUda dlkzVnogYV c1bklHOXVJ RyBGeVpXRn pJSE4xIFky Z2dZWE1nYj IgNWpiMnh2 WjNrcyBJSF poWTJOcGJt IFVnWkdWMl pXeHYgY0cx bGJuUXNJRy BGdVpDQnBi bVpsIFkzUn BiM1Z6SUcg UnBjMlZoYz JWeiBMaUJV YUdseklHIE 52Ym5ScGJu VnYgZFhNZ2 FXNXViMyBa aGRHbHZiaU J3IGJHRjVj eUJoSUcgTn lkV05wWVd3 ZyBjbTlzWl NCcGJpIEJw ZEhNZ1ozSn YgZDNSb0xq eGljaiA0eE 1DNGdSVzF3 IGJHOTVaV1 VnUTMgVnNk SFZ5WlRvZy BUV1Z5WTJz Z2FYIE1nYT I1dmQyNGcg Wm05eUlHbD BjeSBCamIy MXRhWFJ0IF pXNTBJSFJ2 SUggZHZjbX R3YkdGaiBa U0JrYVhabG NuIE5wZEhr Z1lXNWsgSU dWdGNHeHZl VyBWbElIZG xiR3d0IFlt VnBibWN1SU YgUm9aU0Jq YjIxdyBZVz U1SUdWdGNH IGhoYzJsNl pYTWcgWVNC amRXeDBkWC BKbElHOW1J R2x1IFkyeD FjMmx2Ymkg QmhibVFnYz NWdyBjRzl5 ZEN3Z2MzIF J5YVhacGJt Y2cgZEc4Z1 kzSmxZWCBS bElHRnVJR1 Z1IGRtbHli MjV0WlcgNT BJSGRvWlhK bCBJR1Z0Y0 d4dmVXIFZs Y3lCallXNG cgZEdoeWFY WmxMaiB4aW NqNVVhR1Z6 IFpTQmhjM0 JsWTMgUnpJ R2hwWjJocy BhV2RvZENC TlpYIEpqYS tLQW1YTWcg YzJsbmJtbG 1hVyBOaGJu UWdhVzF3IF lXTjBJRzl1 SUcgaGxZV3 gwYUdOaCBj bVVzSUhKbG MyIFZoY21O b0xDQmggYm 1RZ1kyOXlj RyA5eVlYUm xJSEpsIGMz QnZibk5wWW 0gbHNhWFI1 TGp4aSBjaj Q9CiAgICAg ICAgPC9zcG FuPgogICAg ICAgIAogIC AgICAgIA==
See Company Q&A
π Get full analytics about Merck
Sign up for free
or
log in
π₯ Get our free eBook now: "The Checklist Value Investor β A Smarter Way to Pick Stocks"